Logo

Isogen Biosolutions Rebranded as Ocimum Biosolutions

Aug 12, 2008
NEW YORK (GenomeWeb News) – Ocimum Biosolutions of Hyderabad, India, said today that its Isogen Biosolutions oligonucleotide-synthesis business based in Ijsselstein, the Netherlands, will now operate under the Ocimum name.
 
Ocimum acquired the oligo business from Isogen Life Science in 2006. Since that time, it has operated the unit under the Isogen Biosolutions name.
 
The company said today that it decided to rebrand the business “to tap the emerging opportunities and need for globalized solutions in genomics.”
Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.